Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease

Atherosclerosis

Volumn 133, Issue 1, 1997, Pages 111-114

  Jonasson, Lena ^a   Eriksson, Thomas ^a   Dahle'n, Gösta H ^b   Lindblom, Bertil ^c  

^a Department of Internal Medicine   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Autoimmunity; DQB1; DRB1; Lipoprotein(a)

Indexed keywords

HLA DR ANTIGEN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GENE EXPRESSION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 0030814416     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00101-9     Document Type: Article

References (19)

1. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986;6:131.
2. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135:169.
3. Stemme S, Fager G, Hansson GK. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumor necrosis factor and lymphotoxin. Immunology 1990;69:243.
4. Wick G, Schett G, Amberger A, Kleindienst R, Wu Q. Is atherosclerosis an immunologically mediated disease?. Immunol Today 1995;16:27.
5. Stemme S, Hansson GK Immune mechanisms in atherogenesis. Ann med 1994;26:141.
6. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK Expression of class II transplantation antigens on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985;76:125.
7. Klareskog L, Forsum U, Scheynius A. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 1982;79:3632.
8. Bottazzo GF, Dean BM, McNally JM. In situ characterization of autoimmune phenomena and expression of HLA molecules in diabetic insulitis. New Engl J Med 1985;313:353.
9. Hanafusa T, Chiovato L, Doniach D, Pujol-Borrell R, Russell RCG, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Grave's disease: relevance for autoimmunity. Lancet 1983;11:111.
10. Touraine J-L, Betuel H, Pouteil-Noble C, Royo C. HLA class 11 antigens: structure, function and expression in immunodeficiencies, autoimmune diseases and allograft rejections. Adv Nephrol 1989;18:325.
11. Nepom GT, Erlich H. MHC class 11 molecules and autoimmunity. Annu Rev Immunol 1991;9:493.
12. Lernmark A. Molecular biology of IDDM. Diabetologica 1994;37:S73.
13. Dahle'n GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111.
14. Howard GC, Pizzo SV. Lipoprotein (a) and its role in atherothrombotic disease. Lab Invest 1993;69:373.
15. Lindblom B, Holmiund G. Rapid DNA purification for restriction fragment length polymorphism analysis. Gene Anal Tech 1988;5:97.
16. Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994;108:S21.
17. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 1993;341:255.
18. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoproteins. Proc Natl Acad Sci USA 1995;92:3893.
19. Dahle'n GH, Slunga L, Holmlund G, Langö A, Lindblom B. Lp (a) lipoprotein and HLA-DR genotype in early coronary artery disease. Eur J Immunogenet 1993;20:95.